Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

about

Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities.Myc, Oncogenic Protein Translation, and the Role of Polyamines.

P2860

Q47368952-47BCAF12-C91F-4250-8A04-CD854C987940 Q49456418-61DF22A1-8DC6-47C5-BAF8-D070E9C0DB96 Q55414287-6E44C020-1744-449F-8097-C1CE02846887

P2860

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

Item

http://www.wikidata.org/entity/Q36368265

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Inhibiting the oncogenic trans ...... strategy in multiple myeloma.

@ast

Inhibiting the oncogenic trans ...... strategy in multiple myeloma.

@en

type

Item

label

Inhibiting the oncogenic trans ...... strategy in multiple myeloma.

@ast

Inhibiting the oncogenic trans ...... strategy in multiple myeloma.

@en

prefLabel

Inhibiting the oncogenic trans ...... strategy in multiple myeloma.

@ast

Inhibiting the oncogenic trans ...... strategy in multiple myeloma.

@en

P1476

Inhibiting the oncogenic trans ...... c strategy in multiple myeloma

@en

P2093

Chia-Jen Liu

http://www.w3.org/2001/XMLSchema#string

Jiantao Shi

http://www.w3.org/2001/XMLSchema#string

John K Snyder

http://www.w3.org/2001/XMLSchema#string

Lauren E Brown

http://www.w3.org/2001/XMLSchema#string

Nathanael Gray

http://www.w3.org/2001/XMLSchema#string

Timur Yusufzai

http://www.w3.org/2001/XMLSchema#string

William G Devine

http://www.w3.org/2001/XMLSchema#string

Xavier Leleu

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Regulation of translation initiation in eukaryotes: mechanisms and biological targets

Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma

The landscape of somatic copy-number alteration across human cancers.

A tissue-specific atlas of mouse protein phosphorylation and expression

Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation.

New frontiers in translational control of the cancer genome

Discovery of new antimalarial chemotypes through chemical methodology and library development

mRNAs containing extensive secondary structure in their 5' non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E

Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.

P31

scholarly article

P356

10.1126/SCITRANSLMED.AAL2668

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

389

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Roche-Lestienne

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28490664

http://www.w3.org/2001/XMLSchema#string

P932

5718051

http://www.w3.org/2001/XMLSchema#string

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

about

P2860

P2860

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932